StockData
ARS Pharmaceuticals, Inc. logo

ARS Pharmaceuticals, Inc. (SPRY) stock

SPRYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$3.65+0.06 (+1.67%)

Close on Nov 17, 2026Market cap $362.98MP/E –Yield –

ARS Pharmaceuticals gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2023 it was 100.0%.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2023Dec 31, 2023100.0%–

More ARS Pharmaceuticals figures

See a number that looks wrong?